companydata.dkcompanydata.dk

MC2 Therapeutics A/S: Financial statements 2014

CVR: 29526346

Source: annual report 2014, Danish Business Authority

01/01/2014 – 31/12/2014

MC2 Therapeutics A/S (CVR 29526346) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 5,586,065 and a net result of DKK -19,839,747 compared with DKK -25,006,950 the year before. That is an increase of 58.1% compared with the year before. Equity in the 2014 report amounted to DKK 35,387,976. The solvency ratio was 86.2%. The company had 4 employees in the financial year.

Gross Profit
DKK 5,586,065
Profit/Loss
DKK -19,839,747
Equity
DKK 35,387,976
Total Assets
DKK 41,061,295
Employees
4

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2014-5.6 mio.-19.8 mio.35.4 mio.4
2013-3.5 mio.-25 mio.15.9 mio.3
2012-5.2 mio.-31.3 mio.-288.9 mio.4

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2014

MC2 Therapeutics A/S: The 2013 annual report is outFeb 26, 2014

MC2 Therapeutics A/S has published its annual report for 2013. Gross profit came to DKK 3,532,206, and the net result was DKK -25,006,950.

About MC2 Therapeutics A/S

MC2 Therapeutics A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2006. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named MC2 Therapeutics ApS and MC2 BIOTEK ApS. The management consists of Trine Ahlgreen. The board consists of Mads Jørgen Nøhr Clausen (chair), Anders Dahlgaard Hove, John Sørensen Haurum and Tomas Dahl Mikkelsen. The company is owned by Alsmark Invest II ApS, MC2 HOLDING ApS and Selskabet af 4. april 2023 ApS. The company has 8 employees (2026). In 2025, the company reported a gross profit of DKK 22,248,504 and a net result of DKK -7,816,954 compared with DKK -53,006,931 the year before. Equity in the 2025 report amounted to DKK -224,478,927.

Source: annual report 2025, Danish Business Authority